Calcein AM

What We Offer

Calcein AM

Calcein AM | 148504-34-1

Catelog Number A18-0014
Category Fluorescent Enzyme Substrates
Molecular Formula C46H46N2O23
Molecular Weight 994.9
Catalog Number Size Price Quantity
A18-0014 -- $--

Product Introduction

Calcein AM is a non-fluorescent, cell-permeable derivative of calcein, a self-quenching fluorescent dye. Calcein AM can be cleaved to release calcein in cells. Calcein is used as a substrate for multidrug resistance-associated protein 1 (MRP1) and multidrug resistance protein 3 (MDR3, P-glycoprotein 3).

Chemical Information

Synonyms Calcein Acetoxymethyl ester; N,N'-[[3',6'-bis(acetyloxy)-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthene]-2',7'-diyl]bis(methylene)]bis[N-[2-[(acetyloxy)methoxy]-2-oxoethyl]]-glycine, 1,1'-bis[(acetyloxy)methyl] ester
Purity ≥90%
IUPAC Name acetyloxymethyl 2-[[2-(acetyloxymethoxy)-2-oxoethyl]-[[3',6'-diacetyloxy-7'-[[bis[2-(acetyloxymethoxy)-2-oxoethyl]amino]methyl]-3-oxospiro[2-benzofuran-1,9'-xanthene]-2'-yl]methyl]amino]acetate
Canonical SMILES CC(=O)OCOC(=O)CN(CC1=C(C=C2C(=C1)C3(C4=CC=CC=C4C(=O)O3)C5=CC(=C(C=C5O2)OC(=O)C)CN(CC(=O)OCOC(=O)C)CC(=O)OCOC(=O)C)OC(=O)C)CC(=O)OCOC(=O)C
InChI InChI=1S/C46H46N2O23/c1-25(49)60-21-64-41(55)17-47(18-42(56)65-22-61-26(2)50)15-31-11-35-39(13-37(31)68-29(5)53)70-40-14-38(69-30(6)54)32(12-36(40)46(35)34-10-8-7-9-33(34)45(59)71-46)16-48(19-43(57)66-23-62-27(3)51)20-44(58)67-24-63-28(4)52/h7-14H,15-24H2,1-6H3
InChI Key BQRGNLJZBFXNCZ-UHFFFAOYSA-N
Appearance Solid Powder

Product Specification

Excitation 494 nm
Emission 517 nm
Storage Store at -20°C

Computed Properties

XLogP3 2.9
Hydrogen Bond Donor Count 0
Hydrogen Bond Acceptor Count 25
Rotatable Bond Count 32
Exact Mass 994.24913572 g/mol
Monoisotopic Mass 994.24913572 g/mol
Topological Polar Surface Area 305Ų
Heavy Atom Count 71
Formal Charge 0
Complexity 1810
Isotope Atom Count 0
Defined Atom Stereocenter Count 0
Undefined Atom Stereocenter Count 0
Defined Bond Stereocenter Count 0
Undefined Bond Stereocenter Count 0
Covalently-Bonded Unit Count 1
Compound Is Canonicalized Yes

Literatures

PMIDPublication DateTitleJournal
34896433 2022-01-01 Alisertib shows negligible potential for perpetrating pharmacokinetic drug-drug interactions on ABCB1, ABCG2 and cytochromes P450, but acts as dual-activity resistance modulator through the inhibition of ABCC1 transporter Toxicology and applied pharmacology
30925062 2019-05-09 Identification of Thienopyrimidine Scaffold as an Inhibitor of the ABC Transport Protein ABCC1 (MRP1) and Related Transporters Using a Combined Virtual Screening Approach Journal of medicinal chemistry
30217652 2019-02-01 Mifepristone potentiates etoposide toxicity in Hep G2 cells by modulating drug transport Toxicology in vitro : an international journal published in association with BIBRA
30391378 2019-01-01 5-Oxo-hexahydroquinoline derivatives as modulators of P-gp, MRP1 and BCRP transporters to overcome multidrug resistance in cancer cells Toxicology and applied pharmacology
29174985 2018-03-01 Role of P-glycoprotein in deoxynivalenol-mediated in vitro toxicity Toxicology letters

Patents

Publication NumberTitlePriority Date
CN-115177788-A A PCL composite biological collagen membrane with good mechanical strength and cell activity and its application 2022-09-13
CN-115177788-B A kind of PCL composite biological collagen membrane with good mechanical strength and cell activity and its application 2022-09-13
CN-115105624-A A kind of marine polysaccharide-based high-efficiency antibacterial film dressing and preparation method thereof 2022-08-26
CN-115105624-B A marine polysaccharide-based high-efficiency antibacterial film dressing and preparation method thereof 2022-08-26
JP-2022163215-A Neurogenesis stimulant, internal medicine, medium additive, cell diluent additive, medium and cell diluent 2022-08-18
cartIcon
Inquiry Basket